Vaccines - Publications - Faculty & Research

24 Sep 2020
News

The Race for a Vaccine

newly opened facility to accommodate its vaccine development work, and CEO Stéphane Bancel (MBA 2000, AMP 170) welcomed input on the design from the government’s infectious disease experts. For two years, Moderna had been working closely... View Details

Keywords: April White; COVID-19; Scientific Research and Development Services

17 Feb 2022
News

What Can Actually Convince Vaccine Skeptics to Get Their Shots

16 Nov 2020
News

Moderna Announces Promising Vaccine Trial Results

Moderna released promising news on the progress of their coronavirus vaccine this morning, noting that trials showed it to be 94.5% effective. “In this pandemic, what has been awful from a public health standpoint, an economic standpoint,... View Details

24 Apr 2014
News

Saving lives through new vaccine technology

Michael Schrader (MBA 2012) is on a mission to help keep millions of people around the world from dying needlessly. “Right now, 2.4 million people die every year from vaccine-preventable diseases,” says Schrader, cofounder and CEO of Vaxess Technologies. While the cost... View Details

Article

Where America's Vaccine Triumph Fell Short

By: Scott Duke Kominers

Citation

Register to Read

06 Apr 2021
News

Day of 4 Million Vaccines Signals Sharp Turnaround for U.S.

October 2012
Teaching Note

GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships

By: Arthur A. Daemmrich

Citation

Purchase

29 Nov 2020
News

COVID-19 vaccine breakthroughs: What happens now?

22 Jul 2020
News

Even once a vaccine gets approved, big hurdles remain for distribution

15 Jun 2020
Video

Webinar: Science, Business & Vaccine Development to Combat the Pandemic.

16 Jul 2020
News

Too Fast, Too Furious: Is U.S. Vaccine Development Headed in the Wrong Direction?

02 Sep 2021
News

I Expect COVID Vaccine Boosters to Be Mandated by Companies: Gimbel

09 Jun 2020
News

In a Pandemic, What’s the Best Strategy for the Global Vaccine Alliance?

14 Jul 2020
News

Merck CEO says raising COVID-19 vaccine hopes 'a grave disservice' - report

Winter 2022
Article

Distributing a Billion Vaccines: COVAX Successes, Challenges, and Opportunities

By: Eric Budish, Hannah Kettler, Scott Duke Kominers, Erik Osland, Canice Prendergast and Andrew A. Torkelson

By January 2022, the COVAX international vaccine collaboration had allocated over a billion vaccines to over 140 countries. We describe and review the allocation process chosen, which reflected both an objective of equitably distributing vaccines across the world and... View Details

Keywords: Vaccines; Pandemics; Health Care and Treatment; Health Pandemics; Distribution; Supply Chain; Equality and Inequality

Citation

Find at Harvard

Purchase